(Q34602271)

3 August 2017

title

Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo (English)

1 reference

3 August 2017

1 reference

Schwartz B

1

1 reference

3 August 2017

Melnikova VO

2

1 reference

3 August 2017

Tellez C

3

1 reference

3 August 2017

Mourad-Zeidan A

4

1 reference

3 August 2017

Blehm K

5

1 reference

3 August 2017

Zhao YJ

6

1 reference

3 August 2017

McCarty M

7

1 reference

3 August 2017

Adam L

8

1 reference

3 August 2017

Bar-Eli M

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

15 January 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

26

1 reference

3 August 2017

issue

28

1 reference

3 August 2017

page(s)

4049-4058

1 reference

Gene regulation in melanoma progression by the AP-2 transcription factor

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Recent insights into angiogenesis, apoptosis, invasion, and metastasis in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

MMP inhibitors augment fibroblast adhesion through stabilization of focal adhesion contacts and up-regulation of cadherin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Expression of HER2 and its association with AP-2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Cancer of the gastrointestinal tract: early detection or early prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cells by overexpression of AP-2alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Role and regulation of the thrombin receptor (PAR-1) in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Loss of activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Molecular cloning and characterization of AP-2 epsilon, a fifth member of the AP-2 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Primary and secondary prevention in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Cell cycle arrest and apoptosis induction by activator protein 2alpha (AP-2alpha) and the role of p53 and p21WAF1/CIP1 in AP-2alpha-mediated growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Positive influence of AP-2alpha transcription factor on cadherin gene expression and differentiation of the ocular surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

inferred from DOI database lookup

7 January 2021

based on heuristic

A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210193

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210193

1 reference

Dimensions Publication ID

3 August 2017

1016700694

0 references

1 reference